{"title":"Pancreatic Cancer Prediction Using Random Forest Classifier","authors":"D. M, D. Bg","doi":"10.55041/ijsrem36818","DOIUrl":null,"url":null,"abstract":"The goal of this task, \"Pancreatic Cancer Prediction Using Random Forest Classifier,\" is to create a reliable predictive model for categorizing pancreatic diseases. It focuses on three main categories: control cases (no pancreatic disease), benign hepatobiliary diseases (like chronic pancreatitis), and pancreatic ductal adenocarcinoma (pancreatic cancer). The model is trained on biomarker data, such as plasma_CA19_9, creatinine, LYVE1, REG1B, TFF1, and REG1A, by utilizing the capabilities of machine learning, specifically a Random Forest classifier. The goal is to use patient biomarker profiles to accurately distinguish between various illnesses. The purpose of this tool is to help medical practitioners manage pancreatic disorders early on, allocate treatments appropriately, and improve patient outcomes. Keyword: Pancreatic Cancer, Random Forest Classifier, Disease Classification, Machine Learning.","PeriodicalId":504501,"journal":{"name":"INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT","volume":"59 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55041/ijsrem36818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The goal of this task, "Pancreatic Cancer Prediction Using Random Forest Classifier," is to create a reliable predictive model for categorizing pancreatic diseases. It focuses on three main categories: control cases (no pancreatic disease), benign hepatobiliary diseases (like chronic pancreatitis), and pancreatic ductal adenocarcinoma (pancreatic cancer). The model is trained on biomarker data, such as plasma_CA19_9, creatinine, LYVE1, REG1B, TFF1, and REG1A, by utilizing the capabilities of machine learning, specifically a Random Forest classifier. The goal is to use patient biomarker profiles to accurately distinguish between various illnesses. The purpose of this tool is to help medical practitioners manage pancreatic disorders early on, allocate treatments appropriately, and improve patient outcomes. Keyword: Pancreatic Cancer, Random Forest Classifier, Disease Classification, Machine Learning.